Clinical Trials Directory

Trials / Completed

CompletedNCT03502265

Otteroo Case Series

Exploring Otteroo Use In Early Intervention: A Case Series

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
8 Weeks – 66 Months
Healthy volunteers
Not accepted

Summary

Rationale. The Otteroo is a floatie which supports an infant or young child with their head above and their body in water. Researchers are proposing that the Otteroo may be a good "tool" to facilitate exploring the ability to move and control one's body before locomotion develops. Intervention. Otteroo will be used as an adjunct to standard care for 4 weeks.

Detailed description

Objectives or purpose. The purpose of this project is to measure overall developmental status before, during, and after Otteroo experience. Study population or sample characteristics. Participants will be 4 pre-locomotor infants or young children for whom a healthcare provider or caregiver has identified concerns about potential developmental delay. Study methodology. A single-subject research design will be used: measures of infant development will be collected across a 4-week baseline period (standard care), 4 weeks of intervention (standard care and Otteroo use), and a 4 weeks of reversal/retention period (standard care). Study endpoints or outcomes. The end of the study is the final assessment at 12 weeks. Follow-up. None. Statistics and plans for analysis. Researchers will calculate descriptive statistics (mean, range, coefficient of variation) for all measures and describe changes over time, relating the participant's performance at each time point to norm-referenced results for their age.

Conditions

Interventions

TypeNameDescription
OTHEROtterooOtteroo will be provided for 4 weeks of use, to supplement any standard care. Standard care is not provided.

Timeline

Start date
2018-04-03
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2018-04-18
Last updated
2021-11-23
Results posted
2021-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03502265. Inclusion in this directory is not an endorsement.